✦ LIBER ✦

USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA

✍ Scribed by Prentice, H.G.; Janossy, G.; Skeggs, D.; Blacklock, H.A.; Bradstock, K.F.; Goldstein, G.; Hoffbrand, A.V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRETREATMENT OF DONOR BONE MARROW WITH M

✍ Filipovich, AlexandraH.; Ramsay, NormaK.C.; Warkentin, PhyllisI.; Mcglave, Phili 📂 Article 📅 1982 🏛 The Lancet 🌐 English ⚖ 550 KB

Graft-versus-host disease prophylaxis wi

✍ A. H. Filipovich; C. L. Krawczak; J. H. Kersey; P. McGlave; N. K. C. Ramsay; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Muromonab-CD3 (Orthoclone OKT3®), methyl

✍ Benekli, M; Hahn, T; Williams, B T; Cooper, M; Roy, H N; Wallace, P; Stewart, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Ex vivo T-cell depletion with the monocl

✍ W. Heit; D. Bunjes; M. Wiesneth; T. Schmeiser; R. Arnold; G. Hale; H. Waldmann; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Preincubation of donor bone marrow cells

✍ Paul J. Martin; John A. Hansen; E. Donnall Thomas 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 578 KB

T-cell depletion of allogeneic bone marr

✍ Michael Neipp; Beate G Exner; Dipen Maru; Marian Haber; James S Gammie; Si M Pha 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 198 KB